Back to search

Article

Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survival

2022-08-17

Abstract excerpt

<h4>ABSTRACT</h4> Glioblastoma is the most common and aggressive primary brain tumor with poor prognosis, highlighting an urgent need for novel treatment strategies. In this study, we investigated epigenetic regulators of glioblastoma cell survival through CRISPR/Cas9 based genetic ablation screens using a customized sgRNA library EpiDoKOL, which targets critical functional domains of chromatin modifiers. Screens...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9e7db181-4ba8-519b-9be5-01e6f5f80f3c
DOI
10.1101/2022.08.17.504245
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survivalDOI 10.1101/2022.08.17.504245
Select a neighboring publication to make it the new centre.